SEI Investments
PRTK

SEI Investments’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History

SEI Investments’s Portfolio PRTK Stock Details PRTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-209
Closed -$3K – 3852
2018
Q1 		$3K Sell
209
-6,205
-97% -$92.4K ﹤0.01% 3201
2017
Q4 		$114K Sell
6,414
-2,567
-29% -$53.6K ﹤0.01% 2097
2017
Q3 		$225K Buy
8,981
+8,567
+2,069% +$199K ﹤0.01% 1840
2017
Q2 		$10K Buy
+414
New +$9.15K ﹤0.01% 2592

Other funds holding PRTK

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
HCMT
Highland Capital Management (Texas) Dallas, Texas $39M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
APCM
Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

SEI Investments's PRTK Position: Q2 2018 in Review

SEI Investments sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2018, closing a stake of 209 shares — an estimated $3K sold.

SEI Investments first reported a position in PRTK in Q2 2017 and held it in 4 quarters. The position peaked at $225K in Q3 2017. 110 funds tracked by Wall St. Rank hold PRTK as of Q2 2018.

  • SEI Investments reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2018 after selling out during the quarter.
  • SEI Investments sold 209 Paratek Pharmaceuticals, Inc. shares in Q2 2018, an estimated $3K.
  • SEI Investments first reported a position in Paratek Pharmaceuticals, Inc. in Q2 2017 and held it in 4 quarters.
  • SEI Investments's Paratek Pharmaceuticals, Inc. position peaked at $225K in Q3 2017.
  • 110 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2018.

Based on SEI Investments's 13F filing for Q2 2018, filed 3 Aug 2018.